 BOSTON, May 18, 2022 GLOBE NEWSWIRE -- AVEO Oncology Nasdaq: AVEO, a commercial stage, oncology-focused biopharmaceutical company, today announced that members of its senior management team will participate in a fireside chat at the H.C. Wainwright Global Investment Conference on Wednesday, May 25, 2022 at 1:30 p.m. eastern time. 